Home › Funds › Artia Global Partners LP › IONS

Artia Global Partners LP position in IONS

IONIS PHARMACEUTICALS INC · Health Care

Artia Global Partners LP reported holding 144,376 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$11.4M, representing 2.11% of its reported portfolio and ranking #14 among its reported holdings. Artia Global Partners LP has disclosed IONS holdings in 6 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)144.38K sh
Reported value held$11.45M
Portfolio Weight2.11%
First reportedQ2 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's IONS position evolved

Artia Global Partners LP first disclosed a stake in IONS in Q2 2024 at 62,479 shares (US$3.0M). The position peaked in Q2 2026 at 144,376 shares, worth US$11.4M. Across 6 filings, Artia Global Partners LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 144,376 shares valued at US$11.4M. Notable position changes include a 51% trim in Q3 2024 (shares fell 13% over the following quarter), a 140% increase in Q4 2025 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 62.48K $2.98M New
Q3 2024 30.48K $1.22M Reduce
Q3 2025 60.18K $3.94M New
Q4 2025 144.38K $11.42M Add
Q1 2026 144.38K $10.84M Hold
Q2 2026 144.38K $11.45M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has Artia Global Partners LP held IONS?

Artia Global Partners LP has disclosed IONS holdings in 6 of the last 9 reported quarters, going back to Q2 2024.

What is Artia Global Partners LP's current position in IONS?

As of Q2 2026, Artia Global Partners LP holds 144.38K shares of IONS (IONIS PHARMACEUTICALS INC), valued at $11.45M, representing 2.11% of its reported portfolio and ranking #14.

Has Artia Global Partners LP been buying or selling IONS?

In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in IONS. The position peaked in Q2 2026 at 144.38K shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.